The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

The prior settlement agreement also was not approved by people affected by Purdue Pharma's marketing of its OxyContin and other opioid-based pain medications, the court ruled. The current ...

Numerous U.S. states have sued Purdue Pharma for its aggressive marketing and for downplaying OxyContin’s addictiveness. Purdue essentially responded by declaring bankruptcy in 2019. Under the ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

“This epidemic, no doubt, was fueled by Purdue Pharma’s manufacturing and deceptive marketing of OxyContin, a highly potent and addictive drug.” The specific terms require the Sacklers to ...

Purdue Pharma and the members of the Sackler family ... to be overseen by a monitor and will be prevented from lobbying or marketing opioids under the settlement. Purdue is the company that ...

Purdue Pharma and its Sackler family owners have ... of the Sackler family of fueling the epidemic through deceptive marketing of its highly addictive pain medicine. Purdue filed for bankruptcy ...

The deal, agreed to by Purdue Pharma, the Sackler family members ... Connecticut-based Purdue said in a statement. Advertising Representatives for Sackler family members did not immediately ...

NEW YORK — Purdue Pharma and its Sackler family owners have ... the Sackler family of fueling the epidemic through deceptive marketing of its highly addictive pain medicine.